Cell-mediated immunity to low doses of SIVsm in cynomolgus macaques did not confer protection against mucosal rechallenge

Vaccine

Volumn 19, Issue 2-3, 2000, Pages 298-307

  Mäkitalo, Barbro ^a   Böttiger, Per ^a   Biberfeld, Gunnel ^a   Thorstensson, Rigmor ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cytotoxic T lymphocytes (CTL); Simian immunodeficiency virus (SIV); T cell proliferation

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; MACACA; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE;

EID: 0342656492     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00164-X     Document Type: Article

References (60)

1. Chakrabarti L., Guyader M., Alizon M., et al. Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature. 328:1987;543-547.
2. Franchini G., Gurgo C., Guo H-G., et al. Sequence of simian immunodeficiency virus and its relationship to the human immunodeficiency viruses. Nature. 328:1987;539-543.
3. Kestler H., Kodama T., Ringler D.J., et al. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science. 248:1990;1109-1112.
4. Letvin N.L., Daniel M.D., Sehgal P.K., et al. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science. 230:1985;71-73.
5. Letvin N.L. models for AIDS. Immunol. Today. 11:1990;322-325.
6. Fowke K.R. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet. 348:1995;1347-1351.
7. Rowland-Jones S., Sutton J., Ariyoshi K., et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nature Med. 1:1995;59-64.
8. Cheynier R., Langlade-Demoyen P., Marescot M.-R., et al. Cytotoxic T-lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur. J. Immunol. 22:1992;2211-2217.
9. Clerici M., Sison A.V., Berzofsky J.A., et al. Cellular immune factors associated with mother-to-infant transmission of HIV. AIDS. 7:1993;1427-1433.
10. De Maria, A., Cirillo C., Moretta L. Occurrence of HIV-1 specific cytolytic T-cell activity in apparently uninfected children born to HIV-1 infected mothers. J. Inf. Dis. 170:1994;1296-1299.
11. Rowland-Jones S.L., Nixon D.F., Aldhous M.C., et al. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet. 341:1993;860-861.
12. Clerici M., Giorgi J.V., Chou C-C., et al. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J. Inf. Dis. 165:1992;1012-1019.
13. Kelker H.C., Seidlin M., Vogler M., Valentine F.T. Lymphyocytes from some long-term seronegative heterosexual partners of HIV-infected individuals proliferate in response to HIV antigens. AIDS Res. Hum. Retroviruses. 8:1992;1355-1359.
14. Ranki A., Mattinen S., Yarchoan R., et al. T-cell response towards HIV in infected individuals with and without zidovudine therapy, and in HIV-exposed sexual partners. AIDS. 3:1989;63-69.
15. Clerici M., Levin J.M., Kessler H.A., et al. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. JAMA. 271:1994;42-46.
16. McChesney M.B., Collins J.R., Lu D., et al. Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4+ T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV. J. Virol. 72:1998;10029-10035.
17. Miller C.J., Marthas M., Torten J., et al. Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J. Virol. 10:1994;6391-6400.
18. Pauza C.D., Emau P., Salvato M.S., et al. Pathogenesis of SIVmac251 after atraumatic inoculation of the rectal mucosa in rhesus monkeys. J. Med. Primatol. 22:1993;154-161.
19. Salvato M.S., Emau P., Malkovsky M., Schultz K.T., Johnson E., Pauza C.D. Cellular immune response in rhesus macaques infected rectally with low dose simian immunodeficiency virus. J. Med. Primatol. 23:1994;125-130.
20. Trivedi P., Horejsh D., Hinds S., Wu M., Salvato M., Pauza C. Intrarectal transmission of simian immunodeficiency virus in rhesus macaques: selective amplification and host responses to transient or persistent viremia. J. Virol. 70:1996;6876-6883.
21. van Rompay K., Marthas M., Lifson J. Administration of 9-[2-(phosphonomethoxy)-propyl] adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques. AIDS Res Hum Retroviruses. 14:1998;761-773.
22. Dittmer U., Stahl-Hennig C., Coulibaly C., et al. Repeated exposure of rhesus macques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequence of high-dose SIV challenge. J. Gen. Virol. 76:1995;1307-1315.
23. Clerici M., Clark E.A., Polacino P. T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques. AIDS. 8:1994;1391-1395.
24. Putkonen P., Mäkitalo B., Böttiger D., Biberfeld G., Thorstensson R. Protection of human immunodeficiency virus type 2-exposed seronegative macaques from mucosal simian immunodeficiency virus transmission. J. Virol. 71:1997;4981-4984.
25. Quesada-Rolander M., Mäkitalo B., Thorstensson R., et al. Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope. AIDS Res. Hum. Retroviruses. 12:1996;993-999.
26. Fultz P.N., McClure H, Andersson DC, Swenson R.B., Anand R, Srinivasan A. Isolation of a T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys (Cercocebus atys ). Proc. Natl. Acad. Sci. USA. 83:1986;5286-5290.
27. Nilsson C., Thorstensson R., Gilljam G., et al. Protection against monkey-cell grown cell-free HIV-2 challenge in macaques immunized with native HIV-2 envelope glycoprotein gp125. Vaccine Res. 4:1995;165-175.
28. Grankvist O., Bredberg-Rådèn U., Gustafsson Å., et al. Improved detection of HIV-2 DNA in clinical samples using a nested primer-based polymerase chain reaction. J. AIDS. 5:1992;286-293.
29. Walther L., Grankvist O., Mirzai B., et al. Optimization of polymerase chain reaction for detection of HIV type 2 DNA. AIDS Res Hum Retroviruses. 14:1998;1151-1156.
30. Biberfeld G., Thorstensson R., Bergström M., Naucler A., Mendes Costa, C. Enzyme immunoassay for demonstration of antibodies to HIV-2 and HTLV-IV (SIVmac). AIDS. 2:1988;195-199.
31. Andersson S., Mäkitalo B., Thorstensson R., et al. Immunogenicity and protective efficacy of a human immunodeficiency virus type 2 recombinant canarypox (ALVAC) vaccine candidate in cynomolgus monkeys. J. Infect. Dis. 174:1996;977-985.
32. Nilsson C., Mäkitalo B., Thorstensson R., et al. Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm. AIDS. 12:1998;2261-2270.
33. Gilljam G. Envelope glycoproteins of HIV-1, HIV-2, and SIV purified with Galanthus nivalis agglutinin induce strong immune responses. AIDS Res. Hum. Retroviruses. 9:1993;431-438.
34. Teng X-C., Ashworth L.A.E., Sharpe S.A., Dennis M.J., Cranage M.P. Lymphoproliferative responses in macaques immunized with inactivated SIV vaccine. AIDS Res. Hum. Retroviruses. 9:1993;799-801.
35. Manca F., Habeshaw J., Dalgleish A. The naive repertoire of human T helper-cells specific for gp120, the envelope glycoprotein of HIV. J. Immunol. 146:1991;1964-1971.
36. Wahren B., Rosen J., Sandstrom E., Mathiesen T., Modrow S., Wigzell H. HIV-1 peptides induce a proliferative response in lymphocytes from infected persons. J. AIDS. 2:(5):1989;448-456.
37. Jones W.C., Barnard A.L., Slade A., Mills K.H.G. Heterogenity in the recognition of the simian immunodeficiency virus envelope glycoprotein by CD4+T-cell clones from immunized macques. J. Immunol. 149:1992;3120-3126.
38. Dittmer U., Feldmann G., Sauermann U., et al. Specificity of helper T-cells generated from macaques infected with attenuated simian immunodeficiency virus. J. Gen. Virol. 79:1998;1801-1807.
39. Dittmer U., Lüke W., Stahl-Hennig C., et al. Early helper T-cell dysfunction in SIV- but not HIV-2-infected macaques. J. Med. Primatol. 23:1994;21-26.
40. Geretti A.M., Hulskotte E.G., Dings M.E., van Baalen C.A., van Amerongen, G., Osterhaus A.D. Simian immunodeficiency virus (SIV)-specific CD8+ cytotoxic T lymphocyte responses of naive and vaccinated cynomolgus macaques infected with SIVmac32H(J5): quantitative analysis by in vitro antigenic stimulation. Vaccine. 15:1997;1269-1275.
41. Bernard N.F., Yannakis C.M., Lee J.S., Tsoukas C.M. Human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in HIV-exposed seronegative persons. J. Inf. Dis. 179:1999;538-547.
42. Goh W.C., Markee J., Akridge R.E, et al. Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T-cell immunity in the absence of inherited CCR5 coreceptor defects. J. Inf. Dis. 179:1999;548-557.
43. Rowland-Jones S.L., Dong T., Dorrel L., et al. Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors. Immunol Letters. 66:1999;9-14.
44. Harrer T., Harrer E., Kalams S.A., et al. Strong cytotoxic T-cell and week neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res. Hum. Retroviruses. 7:1996;585-592.
45. Rinaldo C.X., Huang X-L., Fan Z., et al. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 69:(9):1995;5838-5842.
46. Schwartz D., Sharma U., Busch M., et al. Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long-term survivor. AIDS Res. Hum. Retroviruses. 10:1994;1703-1711.
47. Rosenberg E.S., Billingsley J.M., Caliendo A.M., et al. Vigorous HIV-1-specific CD4+ T-cell responses associated with control of viremia. Science. 278:1997;1447-1450.
48. Levy J.A., Mackewicz C.E., Barker E. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T-cells. Immunol. Today. 17:1996;217-224.
49. Liu R., Paxton W.A., Choe S., et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 86:1996;367-377.
50. Kaul R., Trabattoni D., Bwayo J.J., et al. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. AIDS. 13:1999;23-29.
51. Kaul R, Plummer FA, Kimani J, et al. HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi. J Immunol 2000;164:1602-11.
52. Mazzoli S., Trabattoni D., Lo Caputo S., et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat. Med. 3:1997;1250-1257.
53. Murphey-Corb M., Wilson L.A., Trichel A.M., et al. Selective induction of protective MHC class I-restricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa. J. Immunol. 162:1999;540-549.
54. Yasutomi Y., Koenig S., Woods R.M., et al. A vaccine-elicited single viral epitope-specific cytotoxic T-lymphocyte response does not protect against intravenous cell-free simian immunodeficiency virus challenge. J. Virol. 96:1995;2279-2284.
55. Hulskotte E.G.J., Geretti A-M., Siebelink K.H.J., et al. Vaccine-induced virus-neutralizing antibodies and cytotoxic T-cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H(J5). J. Virol. 69:1995;6289-6296.
56. Füst G. Enbancing antibodies in HIV infection. Parasitology. 115:1997;S127-S140.
57. Janoff E.N., Wahl S.M., Thomas K., Smith P.D. Modulation of human immunodeficiency virus type 1 infection of human monocytes by IgA. J. Inf. Dis. 172:1995;855-858.
58. Kozlowski P.A., Black K.P., Shen L., Jackson S. High prevalence of serum IgA HIV-1 infection-enhancing antibodies in HIV-infected persons. Masking by IgG. J. Immunol. 154:1995;6163-6173.
59. Takeda A., Tuazon C.U., Ennis F.A. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science. 242:1988;580-583.
60. Spira A.I., Marx P.A., Patterson B.K., et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J. Exp. Med. 183:1996;215-225.